bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.170
-0.400 (-11.20%)
At close: Oct 22, 2026, 4:00 PM EDT
3.160
-0.010 (-0.32%)
After-hours: Oct 22, 2026, 5:10 PM EDT
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes bioAffinity Technologies the 34,398th largest employer in the world and 4,567th in the United States.
Employees
57
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$103,526
Profits / Employee
-$266,408
Market Cap
4.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | 0 | - |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| Biodesix | 334 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| Insight Molecular Diagnostics | 58 |
| Quantum Cyber | 13 |
BIAF News
- 7 days ago - BioAffinity to present new perspectives on CyPath Lung at CHEST 2026 - TheFly
- 7 days ago - bioAffinity Technologies to Present New Perspectives on CyPath® Lung's Use for Cancer Risk Assessment at CHEST 2026 - Business Wire
- 9 days ago - BioAffinity Technologies to present new data at CHEST 2026 - TheFly
- 9 days ago - bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026 - Business Wire
- 9 days ago - bioAffinity Technologies Proxy statement: Proxy filing - Filings
- 13 days ago - WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 13 days ago - BioAffinity Technologies announces closing of $4M registered direct financing - TheFly
- 13 days ago - bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire